Page last updated: 2024-08-23

sufentanil and sb 216763

sufentanil has been researched along with sb 216763 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, YY; Chen, QL; Fang, WP; Gu, EW; Zhang, L; Zhu, Y1

Other Studies

1 other study(ies) available for sufentanil and sb 216763

ArticleYear
Diabetes mellitus abrogates the cardioprotection of sufentanil against ischaemia/reperfusion injury by altering glycogen synthase kinase-3β.
    Acta anaesthesiologica Scandinavica, 2013, Volume: 57, Issue:2

    Topics: Anesthetics, Intravenous; Animals; Blood Pressure; Blotting, Western; Cardiotonic Agents; Diabetes Mellitus, Experimental; Electrocardiography; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Heart Rate; Indoles; Male; Maleimides; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sufentanil; Troponin I

2013